Rise Semi Compliant Balloon Study in Patient With CAD
Coronary Artery DiseaseSingle arm, prospective, multi-center, trial designed to enrol approximately 66 patients. All patients will undergo PCI using at least one RISE SC balloon as per routine clinical practice and will be followed until discharge for data collection. Patients will be enrolled in up to 5 investigational sites in Switzerland. The patients will be followed up until discharge or until 7 days, whichever comes first.
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function
Ischemic Heart DiseaseMicrovascular Coronary Artery Disease2 moreThe DIAST-CMD registry (Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function) is prospective registry which enrolled patients who underwent echocardiography, cnically-indicated invasive coronary angiography and comprehensive physiologic assessments including fractional flow reserve (FFR), CFR, and IMR measurements for at least 1 vessel from Samsung Medical Center. Patients with hemodynamic instability, severe LV dysfunction (left ventricular ejection fraction<40%), a culprit vessel of acute coronary syndrome, severe valvular stenosis or regurgitation were excluded.
NEtwork to Control ATherothrombosis (NEAT Registry)
Coronary Artery DiseasePeripheral Arterial Disease1 moreNEAT is an observational cohort (Prospective registry of real world data) of patients with coronary and peripheral artery disease in an outopatient setting.
Characterization of Different Phenotypes of Microvascular Dysfunction and Their Impact on Angina...
Angina CCS Classe II-IV - IMRRFR1 moreThe aim of the present study will be to identify different phenotypes of microvascular dysfunction and their associations with the severity of anginal symptoms assessed through the Seattle Angina Questionnaire(SAQ-7).
Japan FFRangio Clinical Outcomes Study
Coronary Artery DiseaseThis study aims to collect data on clinical outcomes of real world patients undergoing FFRangio guided treatment for coronary artery disease in Japan and Israel through a retrospective multicentre registry.
Early Results Of Coronary Artery Reconstruction For Extensive Coronary Disease
Coronary ReconstructionEvaluation of early outcome obtained from coronary reconstruction with or without endarterectomy in extensive diseased coronary arteries
Baseline V-RESOLVE Score Guided Versus Angiography Guided Stent Implantation in Coronary Bifurcation...
Coronary Artery DiseaseThe purpose of this study is to investigate whether baseline V-RESOLVE score guided intervention is associated with significant reduction of side branch occlusion rates compared to angiography guided intervention in patients with coronary bifurcation lesions.
Culprit-first in Primary Percutaneous Coronary Intervention
Coronary Artery DiseaseIschemic Heart Disease3 moreThe aim of this study is to assess the impact of culprit-first versus culprit-last percutaneous coronary intervention on the door to balloon time and clinical outcomes in patients with ST-elevation myocardial infarction.
Outcomes of Surgically Ineligible Patients With Multivessel CAD
Coronary Artery DiseaseThe OPTIMUM registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease ("surgical anatomy" according to ACC/AHA Appropriateness Criteria for PCI12) and are deemed ineligible for coronary artery bypass surgery. It is anticipated that 20 sites will be selected to participate in the registry from a national network of leading centers across the United States with recognized expertise in both complex PCI and coronary artery bypass surgery. We will invite leading cardiac centers, as defined by US News and World reports rankings for heart care. Additional sites may be added to meet the target enrollment goal.
Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With...
High Bleeding RiskCoronary Artery Disease1 moreThe study compares two lengths of medication therapy (a shortened versus a prolonged dual antiplatelet therapy) in order to prevent thrombus (blood cloth) formation after the successfully treatment for coronary heart disease with a drug covered stent (metallic tube). This comparison will be done in patients who, compared to the average patient, are more likely to suffer from complications on antiplatelet therapy (bleeding). Both durations are within the current medical recommendations. The aim of this study is to help improve further standard antiplatelet duration guidelines.